We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleSorafenib, a multikinase inhibitor, is effective in vitro against non-hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin.AuthorsRamakrishnan, Vijay; Timm, Michael; Haug, Jessica L.; Kimlinger, Teresa K.; Halling, Timothy; Wellik, Linda E.; Witzig, Thomas E.; Vincent Rajkumar, S.; Adjei, Alex A.; Kumar, ShajiPublicationAmerican Journal of Hematology, 2012, Vol 87, Issue 3, p277ISSN0361-8609Publication typearticleDOI10.1002/ajh.22263